Skip to main content
. 2025 Jul 1;13(7):1619. doi: 10.3390/biomedicines13071619
HCM hypertrophic cardiomyopathy
CMI cardiac myosin inhibitors
LVOT left ventricular outflow tract
oHCM obstructive hypertrophic cardiomyopathy
nHCM non-obstructive hypertrophic cardiomyopathy
ATP adenosine triphosphate
LVEF left ventricular ejection fraction
NYHA New York Heart Association
ECG electrocardiography
KCCQ-CSS Kansas City Cardiomyopathy Questionnaire Clinical Summary Score
HCMSQ-SoB Hypertrophic Cardiomyopathy Symptom Questionnaire Shortness-of-Breath sub-score
HFpEF heart failure with preserved ejection fraction
FDA Food and Drug Administration
EMA European Medicines Agency